Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A Molecular-Modeling Toolbox Aimed at Bridging the Gap Between Medicinal Chemistry and Computational Sciences

Published: Monday, April 08, 2013
Last Updated: Monday, April 08, 2013
Bookmark and Share
Researchers from the University of Basel have designed a versatile single-click tools to assist medicinal chemists in performing two routine modeling tasks.

Abstract
In the current era of high-throughput drug discovery and development, molecular modeling has become an indispensable tool for identifying, optimizing and prioritizing small-molecule drug candidates. The required background in computational chemistry and the knowledge of how to handle the complex underlying protocols, however, might keep medicinal chemists from routinely using in silico technologies. Our objective is to encourage those researchers to exploit existing modeling technologies more frequently through easy-to-use graphical user interfaces. In this account, we present two innovative tools (which we are prepared to share with academic institutions) facilitating computational tasks commonly utilized in drug discovery and development: the VirtualDesignLab estimates the binding affinity of small molecules by simulating and quantifying their binding to the three-dimensional structure of a target protein; and the MD Client launches molecular dynamics simulations aimed at exploring the time-dependent stability of ligand-protein complexes and provides residue-based interaction energies. This allows medicinal chemists to identify sites of potential improvement in their candidate molecule. As a case study, we present the application of our tools towards the design of novel antagonists for the FimH adhesin.

The article is published online in the International Journal of Molecular Sciences and is free to access.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Synthesis and Bioactivity of Analogues of Tropodithietic Acid
The study suggests that the sulfur atoms in the marine antibiotic TDA are not essential for bioactivity, but different modes of action for TDA and its sulfur-free analogue cannot be excluded.
Wednesday, September 10, 2014
Flow Microreactor Synthesis in Organo-Fluorine Chemistry
This review focuses on successful examples on synthesis and reactions of fluorine-containing molecules by the use of flow microreactor systems.
Thursday, February 27, 2014
Reviewing Colchicaceae Alkaloids - Perspectives of Evolution on Medicinal Chemistry
Researchers have shown how thinking about evolution can influence selection of plant material in drug lead discovery.
Monday, February 24, 2014
Efficient Hepatic Delivery of Drugs: Novel Strategies and Their Significance
Significant advances have been made in the development of plant-based hepatoprotective drugs mostly because of their lower toxicity.
Tuesday, December 03, 2013
Light-Activated Pharmaceuticals: Mechanisms and Detection
As new photosensitizing agents are developed, an examination of their localization patterns and photochemistry may aid in the selection of optimal agents for tumor eradication.
Tuesday, December 03, 2013
Design, Synthesis and Hepatoprotective Activity of Analogs of the Natural Product Goodyeroside A
Researchers have developed a highly stereoselective synthetic route of goodyeroside A and its analogs starting from (S)-malic acid has been developed.
Friday, September 06, 2013
Anti-cancer Drug Discovery and Development: Bcl-2 Family Small Molecule Inhibitors
In this article, researchers from The Pennsylvania University College of Medicine discuss the current status of Bcl-2 family small molecule inhibitors in preclinical and clinical development.
Thursday, January 31, 2013
Drug Discovery from Plant Sources: An Integrated Approach
With the cost of development of herbal extracts being substantially lower, it is believed that this strategy would increase the chances of providing effective and safe drugs whilst minimizing the risk of post-marketing withdrawals.
Thursday, November 22, 2012
Ask the Experts: The Challenges and Benefits of Flow Chemistry to Optimize Drug Development
In this article a variety of experts from within Medicinal Chemistry discuss key issues concerning the use of flow chemistry to optimize drug development.
Tuesday, October 23, 2012
Recent Advances in the Medicinal Chemistry of the Metabotropic Glutamate Receptor 1
This review summarizes the medicinal chemistry found in publications on both orthosteric and allosteric modulators of the metabotropic glutamate receptor 1 from 2005 to the present.
Wednesday, October 10, 2012
Pharmacological and Pharmacokinetic Studies of Anti-diabetic Tropolonato-Zn(II) Complexes with Zn(S(2)O(2)) Coordination Mode
In this study researchers from Kyoto Pharmaceutical University have shown that both in vitro insulin-mimetic activity and in vivo hypoglycemic activity are improved by the introduction of zinc complexes that have sulfur ligands.
Monday, September 17, 2012
Using Liposomes as Carriers for Polyphenolic Compounds: The Case of Trans-Resveratrol
In this paper scientists designed and characterized liposome formulations based on rigid bilayers, in order to obtain good compatibility with the rigid aromatic portion of the polyphenol molecular structure.
Tuesday, September 04, 2012
Synthesis and Biological Evaluation of Schiff Bases and Azetidinones of 1-Naphthol
This study looks at the antibacterial and antifungal activity of these synthesized compounds.
Tuesday, September 04, 2012
Identifying Mechanism-of-Action Targets for Drugs and Probes
A chemical information approach to drug-target association can guide therapeutic development and reveal applications to probe biology.
Friday, July 06, 2012
Pharmaceutical Structure Montages as Catalysts for Design and Discovery
This short analysis highlights the usefulness of pharmaceutical structure montages for learning, teaching and as catalysts for research.
Friday, June 08, 2012
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!